SecBot SecBot
8-K ·Filed Apr 16, 2026

PROF

Profound Medical Corp.
NEUTRAL
Impact 3/10
Horizondays Processed7mo ago SEC0001171843-26-002497
8-K context-dependent: Items 7.01
Actionable Insight • Neutral

Traders should monitor the May 7 earnings release and call for updates on revenue, operating performance, and guidance. Until then, no new financial or strategic information is available.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$6.62
T+0 close · Apr 16, 2026 · via day close
Latest settled
+8.01%
T+60 · $7.15
Vs SPY
+0.96%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 16 $6.62entry
  2. T+1 · 7mo ago +0.45%α −0.76% · $6.65
  3. T+5 · 7mo ago +1.96%α +0.98% · $6.75
  4. T+20 · 6mo ago +7.25%α +1.44% · $7.10
  5. T+60 · 4mo ago +8.01%α +0.96% · $7.15
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Profound Medical Corp. announced it will release its first quarter 2026 financial results on May 7, 2026, after market close, followed by a conference call at 4:30 p.m. ET to review the results and discuss business developments. No financial data or guidance was provided in this filing.

Key Facts

  • Profound Medical will release Q1 2026 financial results on May 7, 2026, after market close.
  • Management will host a conference call on May 7, 2026, at 4:30 p.m. ET to discuss results and business developments.
  • No financial results, guidance, or material updates were disclosed in this filing.

Financial Impact

None disclosed, this filing only announces the upcoming earnings release and conference call.

Risk Factors

  • Market volatility may occur ahead of the May 7 earnings release due to lack of forward-looking statements in this filing.
  • No indication of performance direction (positive or negative) was provided, increasing uncertainty.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001171843-26-002497
Exhibit: exh_991.htm0001171843-26-002497
Document: 0001171843-26-002497-index-headers.html0001171843-26-002497
Document: 0001171843-26-002497-index.html0001171843-26-002497
Document: 0001171843-26-002497.txt0001171843-26-002497

US Market Status

Market Closed · Opens Wed (9h 59m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 16, 2026